Intra-arterial chemotherapy with melphalan for intraocular retinoblastoma

摘要

Recently, this journal published a paper from Marr et al1 concerning multi-drug intra-arterial chemotherapy (IAC) for intraocular retinoblastoma. In many centres IAC has quickly garnered exciting interest, emerging as a promising, highly effective alternative for globe conserving treatment. In our institution, IAC with melphalan (IACM) has been performed since June 2008, and topotecan was added in June 2011.